One-time surgical application of genetically engineered autologous keratinocyte sheets provides significant closure and pain ...

The contralateral facial nerve used as a transfacial graft requires a period of 9 to 12 months for the axons to migrate through the graft, causing the facial muscles to be paralyzed during this time ...

ALACHUA, Fla. and TAMPA, Fla. - Axogen, Inc. (NASDAQ: AXGN), specializing in surgical solutions for peripheral nerve injuries, has finished the rolling submission for its Biologics License Application ...

Company News Published 09/06/2024, 07:58 AM 0 Axogen completes FDA submission for nerve graft product AXGN -2.89% ...

2.5x More Graft, No Touching, Nerve Avoidance Dr. Kleiner: “With our system, if you ‘do good carpentry,’ i.e., clear out the disc material to make more room for the graft, then you can put in 2.5x ...

AxoGen, Inc. AXGN announced the initiation of rolling submission of a Biologics License Application (BLA) seeking licensure for its human nerve allograft candidate, Avance Nerve Graft, to the FDA ...

As Axogen, Inc. (NASDAQ: AXGN) progresses with its BLA submission for Avance Nerve Graft, investors are closely monitoring the company's financial health and stock performance. According to ...